[PAR] QoQ Quarter Result on 31-Dec-2017 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2017
Financial Year
2018
Quarter
31-Dec-2017 [#Q2]
Profit Trend
QoQ- -145.23%
YoY- -26.79%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 CAGR
Revenue 2,956 28 2,660 22 1,766 58 1,244 33.44%
PBT -11,227 -4,400 -2,617 -3,573 -1,457 -2,818 -1,502 95.52%
Tax 2,956 0 0 0 0 0 0 -
NP -11,227 -4,400 -2,617 -3,573 -1,457 -2,818 -1,502 95.52%
Tax Rate - - - - - - - -
Total Cost 14,183 4,428 5,277 3,596 3,223 2,876 2,746 72.85%
Ratio Analysis
30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 CAGR
NP Margin -379.84 -15,637.06 -98.38 -15,998.41 -82.52 -4,891.80 -120.68 46.55%
Per Share
30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 CAGR
EPS -0.08 -0.03 -0.02 -0.03 -0.01 -0.03 -0.02 58.74%
EPS Diluted -0.08 -0.03 -0.02 -0.03 -0.01 -0.03 -0.02 58.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.